Clinical Trials

Ongoing clinical trials in molecular imaging and radiotheranostics. Sorted by date of last update.

Title	Phase	Last Update
Lu-177-anti-PD-L1 sdAb in Metastatic Solid Tumors Early Phase 1 Last update: November 2	Early Phase 1	November 2
Lu-177-DOTA-EB-TATE in Adult Patients with Metastatic, Radioactive Iodine Non-Responsive Oncocytic (Hurthle-Cell) Thyroid Cancer Phase 1 Last update: November 2	Phase 1	November 2
68-Ga DOTATATE PET/MRI in the Diagnosis and Management of Somatostatin Receptor Positive CNS Tumors. (DOMINO-START) Phase 4 Last update: October 30	Phase 4	October 30
PULSE Registry: for Patients Receiving Lutetium (Lu-177) Vipivotide Tetraxetan (PULSE) N/A Last update: October 30	N/A	October 30
Pluvicto Real-world Investigation in Survival in Metastatic CRPC (PRISM) N/A Last update: October 30	N/A	October 30
Phase Ib Trial of Lu-177-PSMA-I&T Therapy in Combination with Olaparib and Pembrolizumab in Patients with Metastatic Castration Resistant Prostate Cancer (LumOnate) Phase 1 Last update: October 30	Phase 1	October 30
Observational Study on Lutetium (Lu-177) Vipivotide Tetraxetan to Treat Metastatic Castration Resistant Prostate Cancer N/A Last update: October 29	N/A	October 29
Comparing Retreatment of Lu-177-DOTATATE PRRT versus the Usual Treatment in Patients with Metastatic Unresectable Gastroenteropancreatic Neuroendocrine Tumors, NET RETREAT Trial Phase 2 Last update: October 28	Phase 2	October 28
Evaluation of Neuroinflammation FNOS PET/CT in HIV (+) and (-) Subjects with OUD and Healthy Controls Early Phase 1 Last update: October 28	Early Phase 1	October 28
Phase 2 Clinical Trial of Lu-177-P17-088 for mAPMR Prostate Cancer Phase 2 Last update: October 27	Phase 2	October 27